Article thumbnail

Evidence-Based Design of Fixed-Dose Combinations : Principles and Application to Pediatric Anti-Tuberculosis Therapy

By Elin Svensson, Gunnar Yngman, Paolo Denti, Helen McIlleron, Maria C. Kjellsson and Mats O Karlsson

Abstract

BACKGROUND AND OBJECTIVES: Fixed-dose combination formulations where several drugs are included in one tablet are important for the implementation of many long-term multidrug therapies. The selection of optimal dose ratios and tablet content of a fixed-dose combination and the design of individualized dosing regimens is a complex task, requiring multiple simultaneous considerations. METHODS: In this work, a methodology for the rational design of a fixed-dose combination was developed and applied to the case of a three-drug pediatric anti-tuberculosis formulation individualized on body weight. The optimization methodology synthesizes information about the intended use population, the pharmacokinetic properties of the drugs, therapeutic targets, and practical constraints. A utility function is included to penalize deviations from the targets; a sequential estimation procedure was developed for stable estimation of break-points for individualized dosing. The suggested optimized pediatric anti-tuberculosis fixed-dose combination was compared with the recently launched World Health Organization-endorsed formulation. RESULTS: The optimized fixed-dose combination included 15, 36, and 16% higher amounts of rifampicin, isoniazid, and pyrazinamide, respectively. The optimized fixed-dose combination is expected to result in overall less deviation from the therapeutic targets based on adult exposure and substantially fewer children with underexposure (below half the target). CONCLUSION: The development of this design tool can aid the implementation of evidence-based formulations, integrating available knowledge and practical considerations, to optimize drug exposures and thereby treatment outcomes

Topics: Pharmaceutical Sciences, Farmaceutiska vetenskaper
Publisher: 'Springer Science and Business Media LLC'
Year: 2018
DOI identifier: 10.1007/s40262-017-0577-6
OAI identifier: oai:DiVA.org:uu-346132
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://urn.kb.se/resolve?urn=u... (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles